LifeMD Sees Q3 Sales $48.000M-$51.000M vs $58.547M Est
LifeMD (NASDAQ:LFMD) sees Q3 sales of $48.000 million-$51.000 million vs $58.547 million analyst estimate.
LifeMD says its Q3 sales will be lower than what experts predicted—like getting a smaller allowance than you thought. When a company sells less than people expected, it can make investors worried about whether the business is doing as well as planned.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.